BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29113419)

  • 1. Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy.
    Ai R; Tao Y; Hao Y; Jiang L; Dan H; Ji N; Zeng X; Zhou Y; Chen Q
    Oncotarget; 2017 Oct; 8(46):81617-81635. PubMed ID: 29113419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of autofluorescence in diagnosing oral squamous cell carcinoma and oral potentially malignant disorders: a comparative study with aero-digestive lesions.
    Luo X; Xu H; He M; Han Q; Wang H; Sun C; Li J; Jiang L; Zhou Y; Dan H; Feng X; Zeng X; Chen Q
    Sci Rep; 2016 Jul; 6():29943. PubMed ID: 27416981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of Candida species diversity among patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Sankari SL; Mahalakshmi K; Kumar VN
    BMC Res Notes; 2020 Oct; 13(1):488. PubMed ID: 33081839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unmet Needs and Perspectives in Oral Cancer Prevention.
    Bouaoud J; Bossi P; Elkabets M; Schmitz S; van Kempen LC; Martinez P; Jagadeeshan S; Breuskin I; Puppels GJ; Hoffmann C; Hunter KD; Simon C; Machiels JP; Grégoire V; Bertolus C; Brakenhoff RH; Koljenović S; Saintigny P
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory.
    Dionne KR; Warnakulasuriya S; Zain RB; Cheong SC
    Int J Cancer; 2015 Feb; 136(3):503-15. PubMed ID: 24482244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Immune Cells in the Development of Oral Squamous Cell Carcinoma.
    Caponio VCA; Zhurakivska K; Lo Muzio L; Troiano G; Cirillo N
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant
    Tu HF; Chang KW; Lin SC; Hung WW; Ji SH; Wu HL; Liu CJ
    J Dent Sci; 2022 Apr; 17(2):688-695. PubMed ID: 35756791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cancer and oral potentially malignant disorders in patients with Fanconi anemia - A systematic review.
    Santana NCM; de Sena ACVP; Rocha PADS; de Arruda JAA; Torres-Pereira CC; Abreu LG; Fournier BPJ; Warnakulasuriya S; Silva TA
    Oral Oncol; 2024 Mar; 150():106699. PubMed ID: 38309198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular diagnostics in oral cancer and oral potentially malignant disorders-A clinician's guide.
    Yap T; Celentano A; Seers C; McCullough MJ; Farah CS
    J Oral Pathol Med; 2020 Jan; 49(1):1-8. PubMed ID: 31309636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral squamous cell carcinomas and oral potentially malignant disorders: A Latin American study.
    Gilligan G; Panico R; Lazos J; Morelatto R; Belardinelli P; Criscuolo MI; Bolesina N; Molina Ávila I; Pimentel Solá JM; Rivarola E; Morgante MJ; Ingrassia Tonelli ME; Gimenez J; Doratti P; Werner LC; Prado-Ribeiro AC; Brandão TB; Vechiato-Filho AJ; Cuzzullin MC; Saldivia-Siracusa C; Lopes MA; Agostini M; Romañach MJ; Abrahão AC; Fonsêca TC; Kaminagakura E; Anbinder AL; Santos Alves K; de Almeida Lança ML; Sacsaquispe-Contreras S; Rodriguez Ibazetta K; Gerber-Mora R; Aranda Romo S; Tejeda Nava FJ; Cordero-Torres K; Moreno Silva R; Gonzalez-Arriagada W; Toro R; Silveira FM; Gonzalez N; Vargas PA; Santos-Silva AR; Bologna-Molina R; Villarroel-Dorrego M; Martinez B; Piemonte E
    Oral Dis; 2023 Oct; ():. PubMed ID: 37877476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer.
    Jäwert F; Nyman J; Olsson E; Adok C; Helmersson M; Öhman J
    Oral Oncol; 2021 Oct; 121():105469. PubMed ID: 34371451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemopreventive and Biological Strategies in the Management of Oral Potentially Malignant and Malignant Disorders.
    Viglianisi G; Polizzi A; Grippaudo C; Cocuzza S; Leonardi R; Isola G
    Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders.
    Lorini L; Tomasoni M; Gurizzan C; Magri C; Facchetti M; Battocchio S; Romani C; Ravanelli M; Oberti A; Bozzola A; Bardellini E; Paderno A; Mattavelli D; Lombardi D; Grammatica A; Deganello A; Facchetti F; Calza S; Majorana A; Piazza C; Bossi P
    Front Oncol; 2022; 12():886404. PubMed ID: 35530364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-Cell Infiltration and Immune Checkpoint Expression Increase in Oral Cavity Premalignant and Malignant Disorders.
    Surendran S; Aboelkheir U; Tu AA; Magner WJ; Sigurdson SL; Merzianu M; Hicks WL; Suresh A; Kirkwood KL; Kuriakose MA
    Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Gene-Expression-Based Surrogate of Genomic Instability during Oral Carcinogenesis.
    Truchard E; Bertolus C; Martinez P; Thomas E; Saintigny P; Foy JP
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
    Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
    Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in predictive biomarkers for determining malignant potential of oral potentially malignant disorders.
    Sarode GS; Sarode SC; Maniyar N; Sharma N; Yerwadekar S; Patil S
    Oncol Rev; 2019 Jul; 13(2):424. PubMed ID: 31565195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The onset and progression of oral potentially malignant disorders in Fanconi anemia patients: Highlighting early detection of oral cancer.
    Long Y; Li C; Zhang X; Ren Z; Liu W
    J Dent Sci; 2024 Jan; 19(1):620-625. PubMed ID: 38303850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder.
    Hung KF; Liu CJ; Chiu PC; Lin JS; Chang KW; Shih WY; Kao SY; Tu HF
    Oral Oncol; 2016 Feb; 53():42-7. PubMed ID: 26675284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary inflammatory proteins in patients with oral potentially malignant disorders.
    Dikova VR; Principe S; Bagan JV
    J Clin Exp Dent; 2019 Jul; 11(7):e659-e664. PubMed ID: 31516665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.